Longdaysin |
Catalog No.GC34650 |
Longdaysin es un inhibidor de la vÍa de seÑalizaciÓn de Wnt/β-catenina, que ejerce un efecto antitumoral al bloquear la seÑalizaciÓn de Wnt dependiente de CK1δ/ε. Longdaysin inhibe CK1α, CK1δ, CDK7 y ERK2 con IC50 de 5,6 μM, 8,8 μM, 29 μM y 52 μM, respectivamente.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1353867-91-0
Sample solution is provided at 25 µL, 10mM.
Longdaysin is a CK1α, CK1δ, and extracellular signal-regulated kinase 2 (ERK2) inhibitor with IC50s of 5.6 µM, 8.8 µM, and 52 µM, respectively[1][2]. CKIα|5.6 μM (IC50)|CKIδ|8.8 μM (IC50)|ERK2|52 μM (IC50)
[1]. 1.Griffett K, et al. The mammalian clock and chronopharmacology. Bioorganic & Medicinal Chemistry Letters, 2013, 23(7):1929-1934.. [2]. Hirota T, et al. High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIα as a clock regulatory kinase. PLoS Biol. 2010 Dec 14;8(12):e1000559.
Average Rating: 5
(Based on Reviews and 18 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *